Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Monday, November 9 2009 8:12am ET - U.S. Markets open in 1 hour and 18 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > Warner Chilcott plc Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Warner Chilcott plc Company Profile
Warner Chilcott has a long commute. Though it's domiciled in Ireland, the pharmaceutical manufacturer works mainly in the US, selling brand-name drugs to the country's OB/GYNs and dermatologists. For women, Warner Chilcott makes and markets hormonal contraceptives (including Femcon FE, Loestrin, and Ovcon) and hormone therapies, such as Estrace cream and femhrt. In the area of dermatology, the specialty drug firm makes an acne drug called Doryx. Warner Chilcott has manufacturing facilities in the US, Puerto Rico, and Ireland.
Headlines for Warner Chilcott plc
WARNER CHILCOTT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina
EDGAR Online - 39 minutes ago
Bionovo: Challenges Ahead, But Poised to Move Higher
at Seeking Alpha - 43 minutes ago
InPlay: Warner Chilcott misses by $0.01, reports revs in-line
Briefing.com - 1 hour, 3 minutes ago
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009
PR Newswire - 1 hour, 12 minutes ago
More Headlines...
More on Warner Chilcott plc
Quote Insider
Profile Financials
Reports Analyst Ratings
Research    
Msgs    
Contact Information
Address: 100 Enterprise Dr.
Rockaway, NJ 07866
Phone:973-442-3200
Fax:973-442-3283
Financial Highlights
Fiscal Year End:December
Revenue (2008):938.10 M
Revenue Growth (1 yr):4.30%
Employees (2008):1,115
Employee Growth (1 yr):(-0.90%)
Key People
President, CEO, and Director: Roger M. Boissonneault
EVP and CFO: Paul S. Herendeen
EVP Corporate Development: Anthony D. (Tony) Bruno
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Other
Top Competitors
Bayer HealthCare Pharmaceuticals Inc.
Galderma Laboratories, L.P.
Teva Pharmaceutical Industries Limited (teva)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?